Application Nr Approved Date Route Status External Links
ANDA213665 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Flucytosine Capsules Are Indicated Only In The Treatment Of Serious Infections Caused By Susceptible Strains Of Candida And/or Cryptococcus . Candida: Septicemia, Endocarditis And Urinary System Infections Have Been Effectively Treated With Flucytosine. Limited Trials In Pulmonary Infections Justify The Use Of Flucytosine Cryptococcus: Meningitis And Pulmonary Infections Have Been Treated Effectively. Studies In Septicemias And Urinary Tract Infections Are Limited, But Good Responses Have Been Reported. Flucytosine Capsules Should Be Used In Combination With Amphotericin B For The Treatment Of Systemic Candidiasis And Cryptococcosis Because Of The Emergence Of Resistance To Flucytosine (See Microbiology ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Flucytosine FLUCYTOSINE ZINC896546

Comments